SOURCE: UV Flu Technologies, Inc.

UV Flu Technologies, Inc.

September 24, 2010 16:05 ET

UV Flu Technologies to Be Featured on "The Designing Spaces/Holiday Spaces" TV Show

CENTERVILLE, MA--(Marketwire - September 24, 2010) -  UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the Company and its flagship UV-400 air purification system will be featured on a segment of the "Designing Spaces" TV Show, to be released nationally during the 4th quarter. The show, to be aired on the Women's Entertainment channel, is scheduled for the holiday season and is expected to reach up to 75 million households.

"We are thrilled to be working with Designing Spaces as part of this Holiday Show," said Jack Lennon, President of UV Flu Technologies. "The theme of the segment will be how to stay healthy indoors over the holidays, and our product fits perfectly within this theme. Our ViraTech UV-400 has been laboratory proven to kill airborne bacteria and other contaminants, including odors and volatile organic compounds. There are hundreds of compounds such as formaldehyde, acetone, benzene, etc... that can be found in the average home and which can cause severe respiratory problems."

Mr. Lennon further stated "These volatile compounds are regularly found in furniture, cleaning supplies, building materials, insecticides, and even common household items like hairspray. With families spending over 90% of their time indoors, especially during the winter months and particularly as a result of the proliferation of indoor home theaters and computer games, the public is increasingly susceptible to risks of exposure or transmission of serious illnesses during the holidays. We hope to educate people to the many dangers associated with poor indoor air quality, and also that our UV-400 is a very cost-effective way to protect themselves. We believe this show will provide a tremendous platform to reach one of our key target markets: parents concerned with the health of their families."

Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.

About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available without a prescription.

Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.


UV Flu Technologies, Inc.
John J. Lennon, President & CEO

Contact Information

  • Investor Information:
    Geaux IR Services, Inc.
    Toll-Free: 1-888-355-8838
    Email Contact